Penetration of amphotericin B lipid formulations into pleural effusion
- PMID: 17785511
- PMCID: PMC2151422
- DOI: 10.1128/AAC.01087-07
Penetration of amphotericin B lipid formulations into pleural effusion
Abstract
The penetration of the amphotericin B (AMB) lipid formulations (liposomal AMB, AMB colloidal dispersion, and AMB lipid complex formulations) into pleural effusions in seven critically ill patients was assessed. AMB was detected in all pleural effusion samples at concentrations ranging from 0.02 to 0.43 microg/ml. The penetration ratio was 3 to 44%.
Similar articles
-
Corneal concentrations following systemic administration of amphotericin B and its lipid preparations in a rabbit model.Ophthalmic Res. 2004 May-Jun;36(3):172-6. doi: 10.1159/000077331. Ophthalmic Res. 2004. PMID: 15103209
-
Behavior of amphotericin B lipid complex in plasma in vitro and in the circulation of rats.Antimicrob Agents Chemother. 1997 May;41(5):886-92. doi: 10.1128/AAC.41.5.886. Antimicrob Agents Chemother. 1997. PMID: 9145839 Free PMC article.
-
Amphotericin B lipid formulations in critically ill patients on continuous veno-venous haemofiltration.J Antimicrob Chemother. 2003 Mar;51(3):671-81. doi: 10.1093/jac/dkg139. J Antimicrob Chemother. 2003. PMID: 12615870
-
Amphotericin B lipid preparations: what are the differences?Clin Microbiol Infect. 2008 May;14 Suppl 4:25-36. doi: 10.1111/j.1469-0691.2008.01979.x. Clin Microbiol Infect. 2008. PMID: 18430127 Review.
-
The novel lipid delivery system of amphotericin B: drug profile and relevance to clinical practice.Oncol Nurs Forum. 1998 Jan-Feb;25(1):35-48. Oncol Nurs Forum. 1998. PMID: 9460772 Review.
Cited by
-
A 19-year-old woman with pleuritic chest pain.Can J Infect Dis Med Microbiol. 2015 Mar-Apr;26(2):100-2. doi: 10.1155/2015/652758. Can J Infect Dis Med Microbiol. 2015. PMID: 26015794 Free PMC article. No abstract available.
-
Intra-amniotic Candida albicans Infection Treated With Liposomal Amphotericin B With a Successful Neonatal Outcome.Open Forum Infect Dis. 2024 Jan 31;11(2):ofae047. doi: 10.1093/ofid/ofae047. eCollection 2024 Feb. Open Forum Infect Dis. 2024. PMID: 38370293 Free PMC article.
-
Pharmacokinetics of anidulafungin in pleural fluid during the treatment of a patient with Candida empyema.Antimicrob Agents Chemother. 2011 May;55(5):2478-80. doi: 10.1128/AAC.01560-10. Epub 2011 Mar 14. Antimicrob Agents Chemother. 2011. PMID: 21402857 Free PMC article.
-
Melanoma brain metastases: is it time to reassess the bias?Curr Probl Cancer. 2011 Jul-Aug;35(4):200-10. doi: 10.1016/j.currproblcancer.2011.07.003. Curr Probl Cancer. 2011. PMID: 21911183 Free PMC article.
-
Tissue penetration of antifungal agents.Clin Microbiol Rev. 2014 Jan;27(1):68-88. doi: 10.1128/CMR.00046-13. Clin Microbiol Rev. 2014. PMID: 24396137 Free PMC article. Review.
References
-
- Bellmann, R., P. Egger, and C. J. Wiedermann. 2003. Differences in pharmacokinetics of amphotericin B lipid formulations despite clinical equivalence. Clin. Infect. Dis. 36:1500-1501. - PubMed
-
- Egger, P., R. Bellmann, and C. J. Wiedermann. 2001. Determination of amphotericin B, liposomal amphotericin B, and amphotericin B colloidal dispersion in plasma by high-performance liquid chromatography. J. Chromatogr. B 760:307-313. - PubMed
-
- Espinel-Ingroff, A., K. Boyle, and D. J. Sheehan. 2001. In vitro antifungal activities of voriconazole and reference agents as determined by NCCLS methods: review of the literature. Mycopathologia 150:101-115. - PubMed
-
- Failla, P. J., F. P. Cerise, G. H. Karam, and W. R. Summer. 1995. Blastomycosis: pulmonary and pleural manifestations. South. Med. J. 88:405-410. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources